1 – 20 of 37
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions
(
- Contribution to journal › Article
- 2023
-
Mark
Amyloid formation as a protein phase transition
(
- Contribution to journal › Scientific review
-
Mark
A Kinetic Map of the Influence of Biomimetic Lipid Model Membranes on Aβ42 Aggregation
(
- Contribution to journal › Article
-
Mark
Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates
(
- Contribution to journal › Article
- 2021
-
Mark
Proliferation of Tau 304-380 Fragment Aggregates through Autocatalytic Secondary Nucleation
(
- Contribution to journal › Article
-
Mark
Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates
(
- Contribution to journal › Article
-
Mark
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
(
- Contribution to journal › Article
- 2020
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257(
- Contribution to journal › Article
-
Mark
Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
(
- Contribution to journal › Article
-
Mark
Direct measurement of lipid membrane disruption connects kinetics and toxicity of Aβ42 aggregation
(
- Contribution to journal › Article
-
Mark
Dynamics of oligomer populations formed during the aggregation of Alzheimer’s Aβ42 peptide
(
- Contribution to journal › Article
-
Mark
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
(
- Contribution to journal › Article
- 2019
-
Mark
A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli
(
- Contribution to journal › Article
-
Mark
Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-b aggregates
(
- Contribution to journal › Article
-
Mark
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
(
- Contribution to journal › Article
- 2018
-
Mark
SAR by kinetics for drug discovery in protein misfolding diseases
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(41). p.10245-10250(
- Contribution to journal › Article
-
Mark
Distinct thermodynamic signatures of oligomer generation in the aggregation of the amyloid-β peptide
(
- Contribution to journal › Article
-
Mark
In vitro and in silico assessment of the developability of a designed monoclonal antibody library
(
- Contribution to journal › Article
-
Mark
Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes
(
- Contribution to journal › Article
- 2017
-
Mark
The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation
(
- Contribution to journal › Article